Lataa...
Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?
We present a case report of a heart failure patient after heart transplantation due to end-stage ischemic cardiomyopathy with significant clinical and echocardiographic improvement 3 months after the introduction of sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor. This new class o...
Tallennettuna:
| Julkaisussa: | Indian J Pharmacol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984019/ https://ncbi.nlm.nih.gov/pubmed/32029965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_562_18 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|